Press Release
Press Release
WALTHAM, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a
Read Full Story
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release